Hydrogen Research Study
← Back to Research Library
Preclinical animal evidenceAnimal studyhydrogen-rich water

The protective effect of hydrogen-rich water on rats with type 2 diabetes mellitus.

Mengna Zheng, Han Yu, Yong Xue, Tong Yang, Qiufen Tu, Kaiqing Xiong, Daihua Deng, Lei Lu, Nan Huang · Molecular and cellular biochemistry · 2021

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Diabetes and Metabolic Health
Evidence type Preclinical animal evidence
Publication type Animal study
Hydrogen method hydrogen-rich water

H2HUBB TAKEAWAY

In an animal model, drinking HW suppressed the increase in glucose, total cholesterol, oxidative stress, and inflammation. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.

What the Findings Mean

H2HUBB reviewed how hydrogen-rich water was evaluated in this publication and summarizes the source-grounded findings below. Drinking HW suppressed the increase in glucose, total cholesterol, oxidative stress, and inflammation.

What the Researchers Studied

The study used a preclinical animal experiment.

What Effects Did Molecular Hydrogen Have?

1.0 mg/L H₂; reported treatment duration: 3 weeks. Drinking HW suppressed the increase in glucose, total cholesterol, oxidative stress, and inflammation. The authors concluded that this study indicates that patients with T2DM may be able to improve their condition by supplementing HW as daily drinking water.

Why These Findings Matter

These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.

How Strong Is This Evidence?

This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.

Technical Study Details

H2HUBB classifies this publication as animal study with preclinical animal evidence. The study used a preclinical animal experiment. The hydrogen delivery method was hydrogen-rich water. The reported hydrogen concentration was 1.0 mg/L H₂. The reported treatment duration was 3 weeks.

Limitations and Safety

No separate limitations or safety findings were identified in the source text available to H2HUBB.

Original Study and H2HUBB Research Context

H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.